Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 14,961–14,980 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass I

XZEN GOLD,750 mg, six capsules per bottle, Distributed by: XZEN, City of Los Angeles, CA 90012

by Nova Products, Inc.

Reason
Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN GOLD because FDA laboratory analysis determined they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.
Recall initiated
March 28, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide to retailers and distributors

View recall →

Drug Recall Terminated Historical recordClass I

Black Ant, 4600 mg, four capsules per box, , Manufacturer Timpo Bioengineering Co., Ltd, USA.,

by Nova Products, Inc.

Reason
Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.
Recall initiated
March 28, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide to retailers and distributors

View recall →

Drug Recall Terminated Historical recordClass I

AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158, Renmin Road, Xining City.

by Nova Products, Inc.

Reason
Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.
Recall initiated
March 28, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide to retailers and distributors

View recall →

Drug Recall Terminated Historical recordClass I

COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96

by Bristol-Meyers Squibb

Reason
Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials
Recall initiated
May 12, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide, Canada

View recall →

Drug Recall Terminated Historical recordClass I

THINOGENICS, WEIGHT LOSS MADE EASY! DIETARY SUPPLEMENT, 30 CAPSULES, 30 Count Bottles, THINOGENICS LLC, Nashville, TN 37203 USA.

by Nature's Universe

Reason
Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.
Recall initiated
April 9, 2014
Reported by FDA
September 24, 2014
Distribution
U.S. Nationwide and Canada

View recall →

Drug Recall Terminated Historical recordClass I

Potassium Chloride Injection, 20 mEq per 50 mL, 50 mL Sterile Single Dose Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0703-41, Product Code 2B0822.

by Baxter Healthcare Corp.

Reason
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics
Recall initiated
July 11, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide, Puerto Rico, Singapore, and Hong Kong

View recall →

Drug Recall Terminated Historical recordClass I

0.9% Sodium Chloride Injection USP MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0553-18, Product Code 2B0043.

by Baxter Healthcare Corp.

Reason
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
Recall initiated
July 11, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide, Puerto Rico, Singapore, and Hong Kong

View recall →

Drug Recall Terminated Historical recordClass I

0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

by Baxter Healthcare Corp.

Reason
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
Recall initiated
July 11, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide, Puerto Rico, Singapore, and Hong Kong

View recall →

Drug Recall Terminated Historical recordClass I

Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 62584-143-01

by American Health Packaging

Reason
Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544.
Recall initiated
July 1, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, and Epidural Anesthesia, Not for Spinal Anesthesia, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1162-02

by Hospira Inc.

Reason
Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.
Recall initiated
September 4, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

NORepinephrine 4 mg in 250 mL Sodium Chloride0.9%, For IV Use Only, Flexible Bag, Rx only, UNIQUE PHARMACEUTICALS, Inc.Temple, TX USA 76502

by Unique Pharmaceutical, Ltd

Reason
Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.
Recall initiated
April 17, 2013
Reported by FDA
September 24, 2014
Distribution
TN, PA, and TX

View recall →

Drug Recall Terminated Historical recordClass II

Dermatend Ultra, mole, wart and skin tag remover, For external use only, Ingredient: Distilled Water, Sanguinaria Canadensis, Vegetable Glycerin, Butter of Zinc, Germall Plus, 0.34 OZ (10g) container, Solace International, Inc., Reno, NV 89509, USA

by Solace International Inc

Reason
Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the labeling.
Recall initiated
August 28, 2014
Reported by FDA
September 24, 2014
Distribution
Amazon US and Amazon UK

View recall →

Drug Recall Terminated Historical recordClass II

Dermatend Original, mole, wart and skin tag remover, For external use only, Ingredient: Distilled Water, Sanguinaria Canadensis, Vegetable Glycerin, Butter of Zinc, Germall Plus, 0.17 OZ (5g) container, Solace International, Inc., Reno, NV 89509, USA

by Solace International Inc

Reason
Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the labeling.
Recall initiated
August 28, 2014
Reported by FDA
September 24, 2014
Distribution
Amazon US and Amazon UK

View recall →

Drug Recall Terminated Historical recordClass III

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.

by Taro Pharmaceuticals U.S.A., Inc.

Reason
Failed Content Uniformity Specifications.
Recall initiated
August 25, 2014
Reported by FDA
September 24, 2014
Distribution
United States including: OH, HI, NH, MS, IL, TX, CA.

View recall →

Drug Recall Terminated Historical recordClass III

Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt. Ltd. Bangalore - 560 099, India NDC 60505-3759-9

by Apotex Corp.

Reason
Failed Impurity/Degradation Specification; high out of specification for CAD II degradant
Recall initiated
August 21, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Ibuprofen Tablets, USP, 600 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 68084-0703-01

by American Health Packaging

Reason
Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544
Recall initiated
July 1, 2014
Reported by FDA
September 24, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection, USP, 500 mL, VIAFLEX Plastic Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-0049-03

by Baxter Healthcare Corp.

Reason
Lack of Assurance of Sterility; complaints of mold in the overpouch
Recall initiated
July 30, 2014
Reported by FDA
September 17, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

CHIROTHIN Dietary Supplement, 2 Fl Oz (60 ml), OTC. Manufactured for ChiroNeutraceutical, 877-377-7636, Chesterfield, MO 63005.

by ChiroNutraceutical LLC

Reason
Marketed without an Approved NDA/ANDA; Product contains unapproved hHCG.
Recall initiated
August 20, 2014
Reported by FDA
September 17, 2014
Distribution
U.S. Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

PAXIL (Paroxetine HCL) Tablets 40 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3666-3

by Apotex Inc.

Reason
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Recall initiated
March 24, 2014
Reported by FDA
September 10, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

PAXIL (Paroxetine HCL) Tablets 20 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3664-3

by Apotex Inc.

Reason
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Recall initiated
March 24, 2014
Reported by FDA
September 10, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.